All In Biotech

Free tool

FAERS Monitor: Novolin R

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 019938 or its brand name (Novolin R, Insulin Recombinant Human). Reports on generic versions are filed under their own applications.

Reports

7,159

Serious

5,139

72% of reports

Hospitalization

2,828

Death reported

819

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood glucose increased1,019
  • drug ineffective378
  • nausea376
  • blood glucose decreased361
  • hypoglycaemia298
  • diarrhoea294
  • dyspnoea276
  • renal failure249
  • fatigue239
  • dizziness236
  • fall233
  • death227
  • malaise226
  • vomiting217
  • headache204

Reports by year received

View as table
YearReports
200487
2005162
2006212
2007131
2008201
2009337
2010255
2011212
2012249
2013290
2014357
2015811
2016553
2017549
2018635
2019562
2020297
2021294
2022219
2023167
2024195
2025276
2026108

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,000 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood glucose decreasedSignal36122.220.17,266
hypoglycaemiaSignal29818.216.24,795
blood glucose increasedSignal1,01916.015.114,336
renal failureSignal2495.54.9921
fallSignal2332.11.8128
malaise2261.51.340
dyspnoea2761.41.337
nausea3761.41.343
dizziness2361.41.226
vomiting2171.41.220
diarrhoea2941.31.226
headache2041.00.80
fatigue2390.90.83
drug ineffective3780.80.812
death2270.80.715

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.